BridgeBio has significantly boosted the development of a innovative treatment for ATTR-CM, utilizing Attruby. Early trial information reveals significant outcomes for patients suffering with the severe disease. This emphasis highlights the company’s dedication to managing unmet patient website needs in a heart field. Attruby: BridgeBio's Novel A